#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver abscess Mantle cell lymphoma refractory Bone marrow disorder Chronic hepatitis B Germ cell cancer Biliary neoplasm Leukaemia Haemophilia Brain injury Graft versus host disease Retinal dystrophy Stiff person syndrome B-cell small lymphocytic lymphoma refractory Phenylketonuria Gaucher's disease type I More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Life with Disease Pleural mesothelioma malignant – Basic Information Alagille syndrome Haemophilia A with anti factor VIII – Treatment Testicular leiomyosarcoma X-linked lymphoproliferative syndrome – Diagnostics Glycogen storage disease type II – Trials in Disease IgA nephropathy Breast angiosarcoma metastatic – Life with Disease Factor IX deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Parsaclisib Hydrochloride Lorundrostat STREPTOCOCCUS VIRIDANS Verapamil Thiopental Sodium Fampridine Leflunomide Nemolizumab Tucatinib Cldn6 Car-T Pyridoxine Hydrochloride Bp Chlorpromazine Hydrochloride Gsk3915393 Rct2100 Calcium NALOXEGOL Bms-986449-03 Ralinepag Colistin Sulfate FLUCLOXACILLIN SODIUM More therapies…

    Learn about Your Condition

    Anal cancer stage III Kawasaki's disease Thrombotic microangiopathy Body mass index increased Alcoholism Hypoglycaemia Infantile spasms K-ras gene mutation Blood iron increased Giardiasis Trisomy 21 Blood disorder Richter's syndrome Tertiary adrenal insufficiency Vitiligo More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero Universitaria Consorziale Policlinico…

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari

Piazzale Giulio Cesare 11, Bari, 70124, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Obinutuzumab
    Czechia France Italy Poland Spain

  • Study on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Mepolizumab
    • Depemokimab
    Austria Belgium France Germany Hungary Italy +5

  • Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Givinostat
    Italy

  • Study Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Ph. Eur.
    • Talquetamab
    • Daratumumab
    Belgium Czechia France Germany Greece Italy +3

  • Study of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Palbociclib
    • Belzutifan
    France Germany Italy Poland Spain Sweden

  • Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Italy

  • Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Gemcitabine Hydrochloride
    • Oxaliplatin
    France Germany Greece Italy Spain

  • Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia (in remission)
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Italy

  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Water For Injection
    • Zetomipzomib
    • Methylprednisolone Sodium Succinate
    Croatia France Germany Greece Italy Portugal +1

  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Class III or IV Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Obinutuzumab
    France Germany Italy Poland Spain
Previous Page
1 … 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!